CLARIVATE PLC
For the period ended Jun 30, 2026. Filed Jul 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 29, 2026
CLVT$2.39+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Operations – Unaudited
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| (In millions, except per share data) | 2026 | 2025 | 2026 | 2025 |
| Revenues | $587.3 | $621.4 | $1,172.8 | $1,215.1 |
| Operating expenses: | ||||
| Cost of revenues | 185.5 | 203.6 | 377.6 | 410.6 |
| Selling, general and administrative costs | 181.6 | 181.1 | 357.9 | 359.5 |
| Depreciation and amortization | 185.7 | 190.9 | 369.7 | 376.3 |
| Goodwill and intangible asset impairments | 221.7 | – | 221.7 | – |
| Restructuring costs | 12.1 | 9.3 | 24.1 | 34.0 |
| Other operating expense (income), net | 0.9 | 29.6 | (8.2) | 48.6 |
| Total operating expenses | 787.5 | 614.5 | 1,342.8 | 1,229.0 |
| Income (loss) from operations | (200.2) | 6.9 | (170.0) | (13.9) |
| Interest expense, net | 60.4 | 66.6 | 119.4 | 130.9 |
| Income (loss) before income taxes | (260.6) | (59.7) | (289.4) | (144.8) |
| Provision (benefit) for income taxes | 8.0 | 12.3 | 19.4 | 31.1 |
| Net income (loss) | $(268.6) | $(72.0) | $(308.8) | $(175.9) |
| Per share: | ||||
| Basic | $(0.42) | $(0.11) | $(0.48) | $(0.26) |
| Diluted | $(0.42) | $(0.11) | $(0.48) | $(0.26) |
| Weighted average shares used to compute earnings per share: | ||||
| Basic | 639.4 | 681.3 | 640.0 | 685.5 |
| Diluted | 639.4 | 681.3 | 640.0 | 685.5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.